Login to Your Account

ViroPharma Loses Vancocin Try; FDA Panel Vote Favors Generics

By Donna Young

Wednesday, August 5, 2009
SILVER SPRING, Md. - An FDA panel of outside experts Tuesday in a unanimous vote said regulators should allow makers of generic versions of vancomycin to use in vitro dissolution testing alone to demonstrate bioequivalence for products containing the same ingredients in the same amounts as ViroPharma Inc.'s Vancocin. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription